Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.

With an additional 10% increase in tariffs to China, and a 25% increase in tariffs in Canada and Mexico looming, the optical industry is anticipating paying as much as double in tariff costs compared to last year.

Systane PRO preservative-free is the longest lasting dry eye drop in the Systane portfolio, according to Alcon.

Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.

If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

Learn from the best in Napa Valley.

Among the top 20 contact lens-related searches on Google, 10 were purchase oriented and represented 65% of total volume.

Catch up on the top stories in optometry during the week of February 17-February 21.

The new first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society annual meeting in Washington, DC, from February 26 to March 2.

John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.

Although 2025 is predicted to remain stable, the forecast for the optical industry still remains uncertain.

The study found that 17.4% of Medicare patients needed subspecialized procedures relative to 5.6% of surgeons practicing in rural areas between 2012 and 2022.

Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.

Prominent legislation includes the Corporate Transparency Act and last year's spending bill provision that was struck down.

The agent class’s pleiotropic effects should keep optometrists vigilant.

Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.

The upgraded Myopia Software Package offers comprehensive screening, ortho-k fitting, and myopia management in one device.

MonacoPro, the next evolution of Monaco from Optos, retains the powerful ultra-widefield SLO and spectral domain imaging while adding additional key product features.

Steven T. Reed, OD, talks Optometry's Meeting and public-facing initiatives that optometrists can take advantage of.

The study evaluated 13 teenagers and young adults who had high myopia (−6.50 to −9.25 D).